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Abstract 
A total of 26 lactating sows (DNA 241, DNA Genetics, Columbus, NE) and litters were used in a discovery 
study to evaluate the effects of Calsporin, a direct-fed microbial containing Bacillus subtilis C-3102, on 
fecal microflora of nursing pigs. The treatments consisted of providing a daily oral dose of Calsporin or a 
placebo control to piglets during the nursing phase. Sows were randomly assigned to treatments based 
on farrowing date, parity, and initial BW. The treatments were applied individually to piglets once a day 
from d 2 after farrowing and equalization until weaning on d 19. Sow BW, sow ADFI, piglet BW, piglet 
weight gain, litter size, and mortality were recorded on a weekly basis until weaning. Fecal scoring was 
conducted to categorize the consistency of the feces using a numerical scale from 1 to 5. Also, fecal 
samples were collected directly from the rectum of the piglets and pooled by litter for microbial analysis. 
Fecal scoring and microbial analysis were performed on d 2 after birth, and after 1 or 2 weeks of 
treatment. As expected, and not a primary objective of this study, there was no evidence for differences 
among treatments on sow and litter performance (P > 0.085). There was no evidence for differences on 
fecal score at the beginning of the trial and after 1 or 2 weeks of Calsporin supplementation (P > 0.358). 
Microbial analysis revealed an increase in levels of total Bacillus sp. (P < 0.001) and a decrease in total 
aerobes (P < 0.026) in litters treated with Calsporin. There was no evidence for differences in number of 
Lactobacillus sp., Enterococcus sp., Clostridium perfringens, Enterobacteriaceae, and total anaerobes 
between control- and Calsporin-treated litters (P > 0.05). In conclusion, once per day supplementation of 
Calsporin to nursing pigs resulted in slight changes in fecal microflora, but there was no influence on 
nursing pig fecal consistency. 
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J.C. Woodworth, M.D. Tokach, S.S. Dritz,2 and R.D. Goodband
Summary
A total of 26 lactating sows (DNA 241, DNA Genetics, Columbus, NE) and litters 
were used in a discovery study to evaluate the effects of Calsporin, a direct-fed microbial 
containing Bacillus subtilis C-3102, on fecal microflora of nursing pigs. The treatments 
consisted of providing a daily oral dose of Calsporin or a placebo control to piglets 
during the nursing phase. Sows were randomly assigned to treatments based on far-
rowing date, parity, and initial BW. The treatments were applied individually to piglets 
once a day from d 2 after farrowing and equalization until weaning on d 19. Sow BW, 
sow ADFI, piglet BW, piglet weight gain, litter size, and mortality were recorded on a 
weekly basis until weaning. Fecal scoring was conducted to categorize the consistency of 
the feces using a numerical scale from 1 to 5. Also, fecal samples were collected directly 
from the rectum of the piglets and pooled by litter for microbial analysis. Fecal scoring 
and microbial analysis were performed on d 2 after birth, and after 1 or 2 weeks of treat-
ment. As expected, and not a primary objective of this study, there was no evidence for 
differences among treatments on sow and litter performance (P > 0.085). There was no 
evidence for differences on fecal score at the beginning of the trial and after 1 or 2 weeks 
of Calsporin supplementation (P > 0.358). Microbial analysis revealed an increase 
in levels of total Bacillus sp. (P < 0.001) and a decrease in total aerobes (P < 0.026) 
in litters treated with Calsporin. There was no evidence for differences in number of 
Lactobacillus sp., Enterococcus sp., Clostridium perfringens, Enterobacteriaceae, and total 
anaerobes between control- and Calsporin-treated litters (P > 0.05). In conclusion, 
once per day supplementation of Calsporin to nursing pigs resulted in slight changes in 
fecal microflora, but there was no influence on nursing pig fecal consistency.
Introduction
Feeding strategies to improve performance and preserve health in pigs while minimiz-
ing the use of antibiotics is of great interest for the swine industry. Probiotics are non-
pathogenic live microorganisms that, once ingested in adequate amounts, can improve 
the intestinal microbial balance and benefit the animal.3 The beneficial effects of probi-
1 Appreciation is expressed to Calpis Co., Ltd. (Tokyo, Japan), and Quality Technology International, 
Inc. (Elgin, IL) for microbial analysis and financial support.
2 Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State 
University.
3 Fuller, R. 1989. Probiotics in man and animals. J. Appl. Bacteriol. 66:365-378. 
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otics on intestinal health include the development of a healthy microbiota, prevention 
of colonization by enteric pathogens, increase in digestive capacity, reduced intestinal 
pH, and improvement in gut immunity, maturation, and integrity.4 The strains of 
bacteria that are typically used as probiotics for livestock animals include Lactobacillus 
sp., Bifidobacterium sp., Enterococcus sp., and Bacillus sp.5 Bacillus sp. are Gram-positive 
spore-forming bacteria that are used as probiotics either as single strain or multi-strain 
preparations. Spores are considered stable during feed manufacturing and storage, and 
after ingested can germinate but not proliferate in the intestine. 
Calsporin (Calpis Co. Ltd., Tokyo, Japan) is a direct-fed microbial product based on 
viable spores of a non-genetically modified strain, Bacillus subtilis C-3102. In swine, Ba-
cillus subtilis C-3102 has been fed as a growth promoter in nursery pigs6 and is thought 
to work by increasing the populations of the beneficial intestinal microflora, particu-
larly the Lactobacillus sp.7 However, this product has not been directly administered to 
piglets while they are nursing to determine if improved nursing performance or fecal 
microflora can be observed. Therefore, the objective of the present study was to evaluate 
the effect of a daily oral dose of Calsporin on fecal microflora of nursing pigs.
Procedures
The Kansas State University Institutional Care and Use Committee approved the pro-
tocol used in this experiment. The experiment was conducted at the Kansas State Swine 
Teaching and Research Center in Manhattan, KS. A total of 26 lactating sows (DNA 
241, DNA Genetics, Columbus, NE) and litters were used in the study. The average 
parity was 2.5. At d 110 of gestation, sows were weighed and individually housed in an 
environmentally-controlled and mechanically-ventilated farrowing house. 
Sows and litters were randomly assigned to treatments based on farrowing date and 
parity. Piglets were cross-fostered within 24 h after birth to equalize litter size. Treat-
ments began on d 2 after birth and continued until weaning at approximately d 19 of 
age. Therefore, d 2 and 19 of age corresponded to d 0 and 17 of the trial, respectively. 
The treatments consisted of either a placebo control (n = 14 litters) or supplementation 
of Calsporin (Calpis Co. Ltd., Tokyo, Japan) in the control suspension (n = 12 litters). 
The treatments were applied orally to individual piglets once daily at approximately 
0700 h. Daily Calsporin dosage was 45.0 × 106 CFU/mL, 77.5 × 106 CFU/mL and 
108.3 × 106 CFU/mL for d 0 to 7, d 7 to 14, and d 14 to weaning, respectively, admin-
istered via 1 mL liquid suspension. The liquid suspension was based on a carrier (Head-
start, Animal Science Products, Inc., Nacogdoches, TX, US) alone or with Calsporin. 
The preparation of treatments consisted of dissolving the products in warm water while 
continuously mixing the solution with a magnetic stirrer. The solution was prepared 
4 De Lange, C.F.M., Pluske, J., Gong, J., and Nyachoti, C.M. 2010. Strategic use of feed ingredients and 
feed additives to stimulate gut health and development in young pigs. Livest. Sci. 134:124-134. 
5 Ohashi, Y., and Ushida, K. 2009. Health-beneficial effects of probiotics: Its mode of action. Anim. Sci. 
J. 80:361-371.
6 Marubashi, T., Gracia, M.I., Vilà, B., Bontempo, V., Kritas, S.K., and Piskoríková, M. 2012. The efficacy 
of the probiotic feed additive Calsporin® (Bacillus subtilis C-3102) in weaned piglets: Combined analysis 
of four different studies. J. Appl. Anim. Nut. 1:1-5.
7 Maruta, K., Miyazaki, H., Tadano, Y., Masuda, S., Suzuki, A, Takahashi, H., and Takahashi, M. 1996. 
Effects of Bacillus subtilis C-3102 intake on fecal flora of sows and on diarrhea and mortality rate of their 
piglets. Anim. Sci. Technol. 67(5):403-409.
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immediately before use and given in one oral dose of 1 mL per piglet. Both control and 
treatment suspensions were analyzed for quantification of Bacillus subtilis C-3102.
Sows were allowed ad libitum feed intake during lactation with daily feed delivered and 
recorded by an electronic feeding system (Gestal Solo Feeders Jyga Technologies, Que-
bec City, Quebec, Canada). Sow BW was measured on d 2 post-farrowing and weekly 
until weaning. Piglets were individually weighed on d 2 after birth and on a weekly basis 
until weaning. Fecal scoring was conducted on d 2 after birth, and after 1 and 2 weeks 
of treatment to categorize the consistency of the feces per litter using a numerical scale 
from 1 to 5: 1, hard feces like pellet; 2, firm formed stool; 3, soft moist stool that retains 
shape; 4, soft unformed stool; and 5, watery liquid stool. 
Microbial analysis was performed on fecal samples pooled by litter. Fecal samples were 
collected directly from the rectum of the piglets using mini cotton tip swabs on d 2 
after birth, and after 1 and 2 weeks of treatment. Microbial analysis of fecal samples was 
performed by culture method and quantification (log10 CFU/g) of Calsporin (Bacillus 
subtilis C-3102), Lactobacillus sp., Clostridium perfringens, Salmonella spp., Enterococ-
cus sp., Enterobacteriaceae, total Bacillus sp., total aerobes, and total anaerobes. Limit of 
detection for Calsporin, Salmonella spp. and total Bacillus sp. was 2 × 102.
Data were analyzed using a linear mixed model. Treatment was included as fixed effect 
and block was included as random effect. Litter was the experimental unit. Sow BW, 
sow ADFI, piglet BW, piglet weight gain, and litter size were fitted assuming a nor-
mal distribution of the response variables. Mortality was fitted assuming a binomial 
distribution. Fecal score and microbial analysis were analyzed as repeated measures. 
Statistical models were fitted using the GLIMMIX procedure of SAS (Version 9.4, SAS 
Institute Inc., Cary, NC). Results were considered significant at P ≤ 0.05. 
Results and Discussion
Quantification of Bacillus subtilis C-3102 in the oral products that were provided 
daily to the piglets revealed undetectable levels in the control, and 7.95 × 108 CFU/g, 
10.40 × 108 CFU/g and 9.84 × 108 CFU/g in the Calsporin treatment for d 0 to 7, d 7 
to 14, and d 14 to 17 of the trial, respectively. 
While not a primary objective due to limited replication, sow and litter performance 
was measured. There was no evidence for differences on sow BW (P > 0.085; Table 1) 
or ADFI (P > 0.342) during lactation among treatments. For litter performance, no evi-
dence for differences was observed on piglet BW (P > 0.067) or weight gain (P > 0.163) 
during lactation and no evidence for differences was observed on litter size (P > 0.060) 
or mortality (P > 0.334) throughout the study. Fecal score was reduced from d 0 to 7 
and increased from d 7 to 14 in both treatments, suggesting hardening of feces during 
the first week and softening of feces on the second week of trial, respectively. However, 
there was no evidence for differences on fecal score between control and Calsporin-
treated litters (P > 0.358; Table 1). 
Microbial analysis revealed a change in the numbers of Calsporin (Bacillus subtilis 
C-3102), total Bacillus sp., and total aerobes (P < 0.05; Table 2) in litters treated with 
Calsporin. The detected level of Calsporin was affected by the interaction between treat-
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ment and day (P < 0.001), where the number of Bacillus subtilis C-3102 was increased 
to a greater extent in litters supplemented with Calsporin compared to controls on d 7 
and 14 of treatment. Similarly, an interaction between treatment and day (P < 0.001) 
showed the number of total Bacillus sp. was increased in litters supplemented with Cal-
sporin compared to controls on d 7 and 14 of treatment, but not on d 0. Both the levels 
of Calsporin and total Bacillus sp. in the controls increased over time, whereas levels in 
the Calsporin-treated litters increased from d 0 to 7 and remained constant until d 14 
(P < 0.001). The number of total aerobes was reduced in piglets treated with Calsporin 
for 14 d (P < 0.026) and decreased from d 0 to 14 in both control and Calsporin-treat-
ed piglets (P < 0.001). 
The number of Lactobacillus sp. increased from d 0 to 7 and decreased from d 7 to 14 
(P < 0.001) in both treatments, whereas the detected levels of Enterococcus sp., Entero-
bacteriaceae, and total anaerobes decreased from d 0 to 14 (P < 0.001) in both treat-
ments. There was no evidence for differences in number of Lactobacillus sp., Enterococ-
cus sp., Enterobacteriaceae, and total anaerobes between control and Calsporin-treated 
litters (P > 0.05). The detected level of Clostridium perfringens remained constant 
during the period of treatment, with no evidence for difference between treatments 
(P > 0.331). The analysis revealed non-detectable levels of Salmonella spp. in the feces 
(limit of detection 2 × 102 CFU/g), except for one sample on d 0 in the control treat-
ment (2.75 × 107 CFU/g).
In conclusion, daily supplementation of Calsporin to nursing pigs resulted in slight 
changes in fecal microflora by increasing total Bacillus sp. and decreasing total aerobes 
but did not influence fecal consistency.
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Table 1. Effects of orally dosing piglets with Calsporin on sow and litter performance1 
Item Control Calsporin P <
Sow BW, lb
d 0 489.6 ± 11.7 510.9 ± 12.7 0.181
d 7 482.9 ± 10.1 503.9 ± 10.8 0.135
d 14 478.4 ± 10.5 502.5 ± 11.2 0.099
d 17 476.1 ± 9.7 498.5 ± 10.3 0.085
Sow feed intake, lb
d 0 to 7 11.3 ± 0.5 12.0 ± 0.5 0.342
d 7 to 14 15.7 ± 0.4 16.0 ± 0.4 0.648
d 14 to 17 17.4 ± 0.6 17.2 ± 0.6 0.772
d 0 to 17 14.3 ± 0.4 14.6 ± 0.4 0.570
Piglet BW, lb
d 0 3.58 ± 0.09 3.38 ± 0.09 0.067
d 7 6.65 ± 0.17 6.51 ± 0.18 0.489
d 14 10.71 ± 0.29 10.31 ± 0.31 0.283
d 17 12.25 ± 0.35 11.93 ± 0.37 0.484
Piglet weight gain, lb
d 0 to 7 3.06 ± 0.11 3.17 ± 0.12 0.510
d 7 to 14 4.06 ± 0.15 3.80 ± 0.16 0.163
d 14 to 17 1.52 ± 0.13 1.61 ± 0.14 0.555
Total 8.67 ± 0.30 8.59 ± 0.33 0.849
Litter size, n
d 0 16.0 ± 0.22 15.7 ± 0.23 0.310
d 7 15.7 ± 0.22 15.1 ± 0.23 0.060
d 14 14.9 ± 0.22 14.8 ± 0.23 0.803
d 17 14.8 ± 0.25 14.7 ± 0.27 0.923
Mortality, %
d 0 to 7 1.79 ± 0.88 3.72 ± 1.38 0.445
d 7 to 14 5.00 ± 1.47 1.66 ± 0.95 0.334
d 14 to 17 0.96 ± 0.67 0.56 ± 0.56 0.738
Total 7.47 ± 1.88 5.79 ± 1.79 0.512
Fecal score2
d 0 2.08 ± 0.20 2.11 ± 0.22 0.943
d 7 1.66 ± 0.14 1.52 ± 0.15 0.500
d 14 2.08 ± 0.20 2.36 ± 0.22 0.358
1 A total of 26 sows (DNA 241, DNA genetics) were used in a nursing trial with 14 sows for control and 12 sows 
for Calsporin treatment. Calsporin (Calpis Co. Ltd., Tokyo, Japan) is a direct-fed microbial based on viable spores 
of Bacillus subtilis C-3102. Pigs were given one daily oral dose of Calsporin from d 0 to 17, for a total of 17 days 
of treatment. Day 0 corresponded to day 2 after birth and d 17 corresponded to the day of weaning at ~19 days of 
age. Calsporin dosage was 45 × 106 CFU/mL, 77.5 × 106 CFU/mL and 108.3 × 106 CFU/mL for d 0 to 7, d 7 to 
14 and d 14 to wean, respectively. Values are mean ± standard error of the mean.
2 Consistency of the piglet feces per litter using a numerical scale from 1 to 5: 1, hard feces like pellet; 2, firm 


















Table 2. Effects of orally dosing piglets with Calsporin on fecal microflora1
Control Calsporin P <
Bacteria d 0 d 7 d 14 d 0 d 7 d 14 Treatment Day Trt × Day
Calsporin 2, 3 2.02xa 2.36ya 3.20za 2.24xb 5.55yb 5.74yb <0.0001 <0.0001 <0.0001
SEM 0.06 0.10 0.08 0.06 0.11 0.08
Detected/sampled 2/14 7/14 14/14 7/12 12/12 12/12
Total Bacillus sp.3 2.44x 3.32ya 3.75za 2.67x 5.55yb 5.75yb <0.0001 <0.0001 <0.0001
SEM 0.13 0.10 0.12 0.13 0.11 0.12
Detected/sampled 10/14 14/14 14/14 11/12 12/12 12/12
Lactobacillus sp. 7.84 8.85 8.48 8.04 8.84 8.45 0.620 <0.0001 0.731
SEM 0.16 0.06 0.10 0.19 0.06 0.11
Detected/sampled 14/14 14/14 14/14 11/11 12/12 12/12
Clostridium perfringens 8.74 8.79 8.59 8.72 8.84 8.89 0.331 0.672 0.413
SEM 0.02 0.13 0.15 0.02 0.14 0.17
Detected/sampled 14/14 14/14 14/14 12/12 12/12 12/12
Enterococcus sp. 8.58 7.59 5.41 8.74 7.25 6.70 0.181 <0.0001 0.103
SEM 0.11 0.19 0.52 0.11 0.21 0.56
Detected/sampled 13/13 14/14 12/14 10/10 12/12 12/12
Enterobacteriaceae 9.20 8.33 6.97 9.05 8.34 7.75 0.157 <0.0001 0.137
SEM 0.10 0.09 0.27 0.11 0.10 0.29
Detected/sampled 14/14 14/14 14/14 12/12 12/12 11/12
Total Aerobes 9.32 8.64 8.41 9.28 8.42 8.24 0.026 <0.0001 0.654
SEM 0.09 0.09 0.09 0.10 0.10 0.10
Detected/sampled 14/14 14/14 14/14 12/12 12/12 12/12
Total Anaerobes 9.68x 9.61x 9.27z 9.61x 9.76y 9.18z 0.989 <0.0001 0.033
SEM 0.08 0.06 0.07 0.08 0.07 0.08
Detected/sampled 14/14 14/14 14/14 12/12 12/12 12/12
1 A total of 26 litters were used in a nursing trial with 14 litter for control and 12 litter for Calsporin treatment. Pigs were given one daily oral dose of control or Calsporin from d 2 until d 19 (weaning), 
corresponding to d 0 until 17 of treatment, respectively. Calsporin dosage was 45 × 106 CFU/mL, 77.5 × 106 CFU/mL and 108.3 × 106 CFU/mL for d 0 to 7, d 7 to 14 and d 14 to wean, respectively. 
Fecal samples were collected directly from the rectum of the piglets on d 0, 7 and 14 after the beginning of treatment. Values are mean ± standard error of the mean. Units are log10 CFU/g. The super-
scripts x,y,z indicate significant difference among days within each treatment and a,b indicate significant difference between treatments within each day.
2 Calsporin (Calpis Co. Ltd., Tokyo, Japan) is a direct-fed microbial based on viable spores of Bacillus subtilis C-3102.
3 Limit of detection for Calsporin and total Bacillus sp. was 2 × 102 CFU/g.
